A view to brevity: Brand Institute’s clear-eyed approach to naming AbbVie’s new eyesight drug Vuity

A view to brevity: Brand Institute’s clear-eyed approach to naming AbbVie’s new eyesight drug Vuity
badams
Thu, 12/16/2021 – 09:21